Category
144 releases
WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced it received two…
Aquestive Therapeutics Reports Third Quarter 2026 Financial Results
Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for…
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate at the following upcoming investor conferences in…
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that company management will participate in fireside chats at the following investor…
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its participation in the 2026 Neuroscience Education Institute (NEI) Fall Congress,…
Investors who lost money when DRUG shares sold off on the FDA's partial clinical hold for the planned Phase 2 BMB-101 epilepsy trial may have the…
Nearly nine out of 10 patients experienced a clinical benefit at six months Medtronic receives FDA approval for U.S. labeling update to Symplicity…
Collaborative research projects will focus on studies of cancer dormancy and metastasis BRONX, N.Y., Nov. 3, 2026 — The National Cancer Institute…
As the First-To-File, Lupin is Eligible for 180-Day Generic Exclusivity MUMBAI, India and NAPLES, Fla., Nov. 3, 2026 — Global pharmaceutical leader…
Culmination of 18 Months of Industry Conversations Delivers Updated Data and New Insights on the Pharma Advertising Landscape— NEW YORK, Nov. 3, 2026…
MoleculeMind, an AI-native biological infrastructure company, recently released a new technical report detailing the performance of MMDesign, its…
Beckman Coulter Diagnostics, a Danaher company and a global leader in clinical diagnostics, today announced U.S. FDA clearance of the Access MeMed…
Updated BEAM-302 Phase 1/2 Clinical Data Presented at ERS Demonstrated Durable Increases in Functional AAT and Reductions in Mutant Z-AAT; Completion…
In this free webinar, learn how early-phase biotech teams can improve enrollment predictability by integrating recruitment with feasibility and site…
Medrio CTMS, built for small and scaling sponsors and CROs, is available now through the Early Adopter Program ahead of general availability in early…
StimLabs®, a leading regenerative medicine company, today announces the commercial launch of DermaForm™, an FDA 510(k)-cleared porcine-derived…
Novel twice-daily extended-release tramadol/paracetamol formulation combines Spektus' proprietary AmyloFlex® technology with GEBRO's established…
Largest peer-reviewed study of nonendoscopic esophageal precancer testing to date demonstrates the efficiency and scalability of EsoCheck® cell…
Pharmacist and PBM executive will share why financial and clinical strategies must work together to deliver greater value for plan sponsors…
